Can you take Benfotiamine with Fematrol?
1 drug interaction and 5 additional warnings found for the following 2 drugs:
- benfotiamine
- Fematrol (bisacodyl)
Drug interactions
Moderate drug interactions
Moderate:
bisacodyl benfotiamine
Applies to: Fematrol (bisacodyl) and benfotiamine
Chronic use of bisacodyl may reduce your body's ability to absorb certain vitamins (A, D, E, and K) and minerals like calcium. To reduce the risk of diminished absorption of benfotiamine, it is best to use bisacodyl only occasionally or for short periods. If your doctor does prescribe these medications together, you may need a dose adjustment or special test to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Food/lifestyle interactions
Moderate food/lifestyle interactions
Moderate:
bisacodyl multivitamins with minerals
Applies to: Fematrol (bisacodyl)
Chronic use of bisacodyl may reduce your body's ability to absorb certain vitamins (A, D, E, and K) and minerals like calcium. To reduce the risk of diminished absorption of multivitamins with minerals, it is best to use bisacodyl only occasionally or for short periods. If your doctor does prescribe these medications together, you may need a dose adjustment or special test to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Disease interactions
4 potential interactions Applies to: 4 conditions, including Inflammatory Bowel Disease, Bleeding Disorder, Appendicitis, and Gastrointestinal Obstruction.
Appendicitis
Major:
Fematrol
The bisacodyl in Fematrol has a major potential interaction with Appendicitis.
The use of stimulant laxatives is contraindicated in patients with or who may have acute surgical abdomen or appendicitis. These patients may be candidates for emergency surgery. Stimulant laxatives should also not be administered to patients with abdominal pain, particularly if the cause has not been determined.
Bleeding Disorder
Major:
Fematrol
The bisacodyl in Fematrol has a major potential interaction with Bleeding Disorder.
The use of stimulant laxatives is contraindicated in patients with anal or rectal fissures. These preparations may cause irritation, burning sensation, and proctitis.
Gastrointestinal Obstruction
Major:
Fematrol
The bisacodyl in Fematrol has a major potential interaction with Gastrointestinal Obstruction.
The use of laxatives is contraindicated in patients with intestinal obstruction disorders. Patients with intestinal obstruction disorders may need their underlying condition treated to correct the constipation. Some laxatives require reduction in the colon to their active form to be effective which may be a problem in patients with intestinal obstruction.
Inflammatory Bowel Disease
Major:
Fematrol
The bisacodyl in Fematrol has a major potential interaction with Inflammatory Bowel Disease.
The use of laxatives is contraindicated in patients with inflammatory bowel disease. Patients with inflammatory bowel disease may experience colonic perforation with use of stimulant laxatives.
Report options
More resources
benfotiamine
A total of 15 drugs are known to interact with benfotiamine.
- Benfotiamine is in the drug class vitamins.
- Benfotiamine is used to treat Dietary Supplementation.
Fematrol
A total of 276 drugs are known to interact with Fematrol.
- Fematrol is in the drug class laxatives.
- Fematrol is used to treat the following conditions:
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.